A QSAR Study for Antileishmanial 2-Phenyl-2,3-dihydrobenzofurans

Bernal FA, Schmidt TJ

Research article (journal) | Peer reviewed

Abstract

Leishmaniasis, a parasitic disease that represents a threat to the life of millions of people around the globe, is currently lacking effective treatments. We have previously reported on the antileishmanial activity of a series of synthetic 2-phenyl-2,3-dihydrobenzofurans and some qualitative structure–activity relationships within this set of neolignan analogues. Therefore, in the present study, various quantitative structure–activity relationship (QSAR) models were created to explain and predict the antileishmanial activity of these compounds. Comparing the performance of QSAR models based on molecular descriptors and multiple linear regression, random forest, and support vector regression with models based on 3D molecular structures and their interaction fields (MIFs) with partial least squares regression, it turned out that the latter (i.e., 3D-QSAR models) were clearly superior to the former. MIF analysis for the best-performing and statistically most robust 3D-QSAR model revealed the most important structural features required for antileishmanial activity. Thus, this model can guide decision-making during further development by predicting the activity of potentially new leishmanicidal dihydrobenzofurans before synthesis.

Details about the publication

JournalMolecules
Volume28
Article number3399
StatusPublished
Release year2023
Language in which the publication is writtenEnglish
DOI10.3390/molecules28083399
Link to the full texthttps://www.mdpi.com/1420-3049/28/8/3399
Keywords2-phenyl-2,3-dihydrobenzofurans; Leishmania; 3D-QSAR; QSAR; neolignan analogues

Authors from the University of Münster

Bernal, Freddy Alexander
Professur für Pharmazeutische Biologie und Phytochemie (Prof. Schmidt)
Schmidt, Thomas
Professur für Pharmazeutische Biologie und Phytochemie (Prof. Schmidt)